These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19172584)

  • 1. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.
    Yi M; Meric-Bernstam F; Middleton LP; Arun BK; Bedrosian I; Babiera GV; Hwang RF; Kuerer HM; Yang W; Hunt KK
    Cancer; 2009 Mar; 115(5):962-71. PubMed ID: 19172584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
    Goldflam K; Hunt KK; Gershenwald JE; Singletary SE; Mirza N; Kuerer HM; Babiera GV; Ames FC; Ross MI; Feig BW; Sahin AA; Arun B; Meric-Bernstam F
    Cancer; 2004 Nov; 101(9):1977-86. PubMed ID: 15389473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
    Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
    Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
    Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
    Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
    Pinell-White XA; Kolegraff K; Carlson GW
    Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy.
    Agarwal S; Pappas L; Matsen CB; Agarwal JP
    Cancer Med; 2020 Nov; 9(21):8043-8052. PubMed ID: 32918537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
    Yi M; Hunt KK; Arun BK; Bedrosian I; Barrera AG; Do KA; Kuerer HM; Babiera GV; Mittendorf EA; Ready K; Litton J; Meric-Bernstam F
    Cancer Prev Res (Phila); 2010 Aug; 3(8):1026-34. PubMed ID: 20647335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should the use of contralateral prophylactic mastectomy be increasing as it is?
    Wood WC
    Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
    Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult Histopathology and Its Predictors in Contralateral and Bilateral Prophylactic Mastectomies.
    Mattos D; Gfrerer L; Ling IT; Reish RG; Hughes KS; Halpern EF; Cetrulo C; Colwell AS; Winograd JM; Yaremchuk MJ; Austen WG; Liao EC
    Ann Surg Oncol; 2016 Mar; 23(3):767-75. PubMed ID: 26577123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contralateral Prophylactic Mastectomy: Challenging Considerations for the Surgeon.
    Angelos P; Bedrosian I; Euhus DM; Herrmann VM; Katz SJ; Pusic A
    Ann Surg Oncol; 2015 Oct; 22(10):3208-12. PubMed ID: 26259752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.
    Ashfaq A; McGhan LJ; Pockaj BA; Gray RJ; Bagaria SP; McLaughlin SA; Casey WJ; Rebecca AM; Kreymerman P; Wasif N
    Ann Surg Oncol; 2014 Sep; 21(9):2934-40. PubMed ID: 24756811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contralateral Prophylactic Mastectomy: Factors Predictive of Occult Malignancy or High-Risk Lesion and the Impact of MRI and Genetic Testing.
    Erdahl LM; Boughey JC; Hoskin TL; Degnim AC; Hieken TJ
    Ann Surg Oncol; 2016 Jan; 23(1):72-7. PubMed ID: 26065870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors for contralateral prophylactic mastectomy in breast cancer patients.
    Fu Y; Zhuang Z; Dewing M; Apple S; Chang H
    Int J Clin Exp Pathol; 2015; 8(4):3748-64. PubMed ID: 26097557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations.
    Xia C; Schroeder MC; Weigel RJ; Sugg SL; Thomas A
    Ann Surg Oncol; 2014 Dec; 21(13):4133-8. PubMed ID: 24934585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contralateral prophylactic mastectomy.
    Rai SS; Mahabir RC; Roberts JW; Song J; Hamid KS; White RR
    Ann Plast Surg; 2011 Sep; 67(3):215-9. PubMed ID: 21508813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy.
    Allué Cabañuz M; Domingo Bretón M; Chóliz Ezquerro J; Arribas Del Amo MD; Güemes Sánchez AT
    Cir Esp (Engl Ed); 2020 Dec; 98(10):612-617. PubMed ID: 32505558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
    Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
    Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the increasing trend of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ: Analysis of Surveillance, Epidemiology, and End Results data.
    You Q; Chen K; Li Y; Lai J; Fang Y; Shen S; Liu Y; Su F; Yu F
    Breast; 2018 Aug; 40():147-155. PubMed ID: 29804045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.
    King TA; Sakr R; Patil S; Gurevich I; Stempel M; Sampson M; Morrow M
    J Clin Oncol; 2011 Jun; 29(16):2158-64. PubMed ID: 21464413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.